Physician profile
Eric C Christensen
NPI 1962478503
$3,877.48
in general payments reported to CMS, 2019-2025
35 companies · $1,041 in 2025
The $1,041 reported for 2025 was more than what 80% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $410 · 2021: $346 · 2022: $704 · 2023: $532 · 2024: $596 · 2025: $1,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,168.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $502.98 | 2020-2025 | Taltz, Olumiant, Ebglyss |
| Janssen Biotech, INC. | $476.10 | 2023-2025 | Tremfya |
| Optinose US, INC. | $423.28 | 2019-2025 | |
| Glaxosmithkline, LLC. | $380.77 | 2021-2025 | Nucala |
| Ucb, INC. | $297.52 | 2019-2025 | Bimzelx |
| Genzyme Corporation | $249.11 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $181.03 | 2019-2025 | Libtayo, Dupixent |
| Amgen INC. | $144.15 | 2020-2024 | Otezla |
| Grifols USA, LLC | $104.69 | 2023-2024 | Xembify |
| Acclarent, INC | $104.49 | 2019-2022 | |
| Organogenesis INC. | $92.44 | 2023-2025 | Puraply Wound Matrix, Puraply |
| Aerin Medical INC. | $89.36 | 2024-2025 | |
| Abbvie INC. | $86.45 | 2021-2022 | |
| Almirall LLC | $76.77 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $74.89 | 2019-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $71.88 | 2020-2022 | |
| Intersect Ent, INC. | $70.95 | 2019-2021 | |
| Biofrontera INC. | $50.34 | 2020-2022 | |
| Incyte Corporation | $46.31 | 2023-2024 | Opzelura |
| Jazz Pharmaceuticals INC. | $43.33 | 2020 | |
| Hologic Sales and Service, LLC | $33.19 | 2023 | Coolseal Generator |
| Medtronic, INC. | $28.98 | 2023 | Propel |
| E.R. Squibb & Sons, L.L.C. | $27.83 | 2025 | Sotyktu |
| Astrazeneca Pharmaceuticals LP | $27.58 | 2021-2025 | Tezspire |
| Leo Pharma INC. | $25.36 | 2024 | Adbry |
| Mallinckrodt Hospital Products INC. | $23.80 | 2025 | Acthar |
| Kowa Pharmaceuticals America, INC. | $23.34 | 2022 | |
| Merck Sharp & Dohme LLC | $19.36 | 2023 | |
| Vyne Pharmaceuticals INC. | $17.68 | 2020 | |
| Janssen Pharmaceuticals, INC | $16.84 | 2024 | Tremfya |
| Kyowa Kirin, INC. | $14.49 | 2024 | Poteligeo |
| Helsinn Therapeutics (U.S.), INC. | $14.38 | 2020 | |
| Endogastric Solutions, INC | $12.96 | 2022 | |
| Agiliti Surgical, INC. | $12.59 | 2019 | |
| Hospira, INC. | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Christensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.